Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SURF

Surface Oncology (SURF) Stock Price, News & Analysis

Surface Oncology logo

About Surface Oncology Stock (NASDAQ:SURF)

Advanced Chart

Key Stats

Today's Range
$1.07
$1.07
50-Day Range
$0.88
$1.08
52-Week Range
$0.56
$1.43
Volume
N/A
Average Volume
430,375 shs
Market Capitalization
$65.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SURF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surface Oncology and its competitors with MarketBeat's FREE daily newsletter.

SURF Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Q3 2024 Heron Therapeutics Inc Earnings Call
See More Headlines

SURF Stock Analysis - Frequently Asked Questions

Surface Oncology, Inc. (NASDAQ:SURF) posted its earnings results on Thursday, November, 4th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.40) by $0.04. The firm had revenue of $0.39 million for the quarter.

Surface Oncology (SURF) raised $84 million in an IPO on Thursday, April 19th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Goldman Sachs, Cowen and Evercore ISI served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surface Oncology investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), NIO (NIO), Zoom Communications (ZM), QUALCOMM (QCOM) and Workhorse Group (WKHS).

Company Calendar

Last Earnings
11/04/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:SURF
CIK
1718108
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.53)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.59 million
Net Margins
N/A
Pretax Margin
-211.95%
Return on Equity
-107.81%
Return on Assets
-65.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.60
Quick Ratio
3.60

Sales & Book Value

Annual Sales
$30 million
Price / Sales
2.17
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.81 per share
Price / Book
1.32

Miscellaneous

Outstanding Shares
60,824,000
Free Float
53,525,000
Market Cap
$65.08 million
Optionable
Not Optionable
Beta
1.75
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:SURF) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners